Zynex Inc Marktkapitalisierung
Was ist das Marktkapitalisierung von Zynex Inc?
Marktkapitalisierung von Zynex Inc ist $534.00M
Was ist die Definition von Marktkapitalisierung?
Die Marktkapitalisierung ist der Marktwert zu einem Zeitpunkt, zu dem die Aktien eines börsennotierten Unternehmens im Umlauf sind, und ist gleich dem Aktienkurs zu diesem Zeitpunkt multipliziert mit der Anzahl der im Umlauf befindlichen Aktien .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Marktkapitalisierung von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Zynex Inc
Was macht Zynex Inc?
zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. zynex neurodiagnostics develops devices for emg and eeg diagnostic applications within neurology disciplines. zynex medical's product line is fully developed, fda/ce cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. zynex monitoring solutions and zynex neurodiagnostics are currently both in the development stages without any significant revenues.
Unternehmen mit marktkapitalisierung ähnlich Zynex Inc
- Lux Industries hat Marktkapitalisierung von $533.28M
- Equitas hat Marktkapitalisierung von $533.39M
- Aarti Drugs hat Marktkapitalisierung von $533.44M
- Solaris Resources hat Marktkapitalisierung von $533.49M
- Jiangsu Lettall Electronic Co hat Marktkapitalisierung von $533.70M
- The North American Income Trust Plc hat Marktkapitalisierung von $533.74M
- Zynex Inc hat Marktkapitalisierung von $534.00M
- Australian Pharmaceutical Industries hat Marktkapitalisierung von $534.39M
- Orient Refractories hat Marktkapitalisierung von $534.44M
- Vitru Ltd hat Marktkapitalisierung von $534.56M
- Surge hat Marktkapitalisierung von $534.59M
- Hunting PLC hat Marktkapitalisierung von $534.61M
- Bank of Cyprus Public hat Marktkapitalisierung von $534.62M